Cangrelor

Cangrelor
Results: 2

#	Item
1	Cangrelor An IV P2Y12 Inhibitor for the Reduction of Thrombotic Events in Patients Undergoing PCI or Requiring Bridging to Surgery Presentation to the Cardiovascular and Renal Advisory Committee Add to Reading List Source URL: www.fda.gov Language: English Nucleotides Purines Organochlorides Bristol-Myers Squibb Clopidogrel Prodrugs Antiplatelet drug Cangrelor Platelet Medicine Chemistry Organic chemistry
2	Cangrelor for Percutaneous Coronary Intervention (PCI) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) Add to Reading List Source URL: www.fda.gov Language: English Bristol-Myers Squibb Clopidogrel Organochlorides Prodrugs Sanofi Medical emergencies Myocardial infarction Conventional PCI Prasugrel Medicine Organic chemistry Chemistry

UPDATE